Hangzhou Juguang Import and Export Co., Ltd. – Trademark Portfolio
Entity Type: 99
Hangzhou Juguang Import and Export Co., Ltd. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. Currently, 6 trademarks are registered. Notable registered marks include FONUBEE, LYFEASE, BLEDHEAL, DIATMOON, and LEITEAFUL. The owner is based in Hangzhou, Zhejiang.
707-709, Bldg. 1, No. 2 Kejiyuan Rd.,
Baiyang St., Qiantang New Dist.,
Hangzhou, Zhejiang 310000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Hangzhou Juguang Import and Export Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Hangzhou Juguang Import and Export Co., Ltd. have?
Hangzhou Juguang Import and Export Co., Ltd. has 6 U.S. trademarks filed with the USPTO. Of these, 6 registered.
What trademark classes does Hangzhou Juguang Import and Export Co., Ltd. file in?
Hangzhou Juguang Import and Export Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Hangzhou Juguang Import and Export Co., Ltd.'s most well-known trademarks?
Hangzhou Juguang Import and Export Co., Ltd.'s registered trademark portfolio includes well-known marks such as FONUBEE, LYFEASE, BLEDHEAL, DIATMOON, and LEITEAFUL. These are among 6 currently registered trademarks in the portfolio.
What is Hangzhou Juguang Import and Export Co., Ltd.'s trademark registration success rate?
Hangzhou Juguang Import and Export Co., Ltd. has a 100% trademark registration rate, with 6 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.